ZAO BIOCOM
Lupin shares end nearly 2% up on Russia's Biocom acquisitionAfter rising 2.52 per cent to Rs 1,917 in intra-day trade, shares of Lupin finally ended at Rs 1,900.45, up 1.64 per cent on the BSE.
Lupin acquires Russian drug firm BiocomThe acquisition marks Mumbai-based firm's entry into the Russian pharmaceutical market which recorded RUB 765 billion in sales.
- Load More